CTRI/2017/10/009962招募中未知
Evaluation of efficacy of vatsyayan plus (capsule)in the management of male impotency -Double blind placebo control clinical study
MB Life Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subjects with Male Impotency fulfilling the diagnostic criteria of IIEF-15
- •2.Subjects with signs & symptoms of Klaibya
- •3.Male subjects with age between 21-45 years
- •4.Willing to give consent for participating in the study
排除标准
- •1.Subjects with H/o BPH, Severe HTN & cardiac disease
- •2.Sexually transmitted diseases.
- •3.Patients with other major systemic disorders which interfere with the treatment will be excluded
- •4.Known case of genetic abnormalities.
- •5.Patients with known major psychological disorders.
- •6.Spinal injury and major pelvic surgery.
- •7.Pyeronieâ??s disease.
- •8.Priapism.
- •9.Any other conditions which in the opinion of investigator will place the subject at risk or will influence the conduct of study or interpretation of results
研究者
相似试验
尚未招募
1 期
Action of the vatsyayanplus in male impotencyCTRI/2018/05/013980MS MB Life Sciences
尚未招募
3 期
Akalaja Jarajanya Lakshana in the apparently healthy volunteers treated By Vayasthapana Gana Yapna BastiCTRI/2023/11/060076Dr. Vikram D Patani
尚未招募
3 期
A clinical study to compare the effects of Yavanyadi and Nishakathakadi tablets as an add-on medication in patients with Type 2 Diabetes mellitus.CTRI/2024/07/069893Dr Deepika GI
已完成
不适用
Vyvanse Capsules Specified Drug Use-results Survey (Surveillance regarding pediatric long-term use)Attention deficit/hyperactivity disorderJPRN-UMIN000039018Takeda Pharmaceutical Co., Ltd.1,820
已完成
不适用
Vyvanse Capsules Specified Drug Use-results Survey (Surveillance regarding pediatric use)Attention deficit/hyperactivity disorderJPRN-UMIN000046038Takeda Pharmaceutical Co., Ltd.88